| INKDX | RGAGX | INKDX / RGAGX | |
| Total Expense Ratio | 0.71 | 0.29 | 245% |
| Annual Report Gross Expense Ratio | 0.71 | 0.29 | 245% |
| Fund Existence | 3 years | 17 years | - |
| Gain YTD | -42.044 | 5.796 | -725% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.27B | 357B | 1% |
| Annual Yield % from dividends | N/A | 0.52 | - |
| Returns for 1 year | -42.04 | 1.96 | -2,148% |
| Returns for 3 years | -33.32 | 37.42 | -89% |
| Returns for 5 years | N/A | 15.08 | - |
| Returns for 10 years | N/A | 103.10 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PLTW | 16.87 | 0.16 | +0.96% |
| Roundhill PLTR WeeklyPay ETF | |||
| PKB | 100.29 | 0.59 | +0.59% |
| Invesco Building & Construction ETF | |||
| PGX | 10.73 | -0.01 | -0.09% |
| Invesco Preferred ETF | |||
| TIIV | 30.54 | -0.04 | -0.12% |
| AAM Todd International Intrinsic Val ETF | |||
| IBBQ | 32.10 | -0.60 | -1.84% |
| Invesco Nasdaq Biotechnology ETF | |||